UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:NEBL-KMT2A |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: NEBL-KMT2A | FusionPDB ID: 58344 | FusionGDB2.0 ID: 58344 | Hgene | Tgene | Gene symbol | NEBL | KMT2A | Gene ID | 10529 | 4297 |
Gene name | nebulette | lysine methyltransferase 2A | |
Synonyms | C10orf113|LASP2|LNEBL|bA165O3.1 | ALL-1|CXXC7|HRX|HTRX1|MLL|MLL1|MLL1A|TRX1|WDSTS | |
Cytomap | 10p12.31 | 11q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | nebuletteLIM and SH3 protein 2LIM-nebuletteactin-binding Z-disk protein | histone-lysine N-methyltransferase 2ACXXC-type zinc finger protein 7lysine (K)-specific methyltransferase 2Alysine N-methyltransferase 2Amixed lineage leukemia 1myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)trithorax-like | |
Modification date | 20200313 | 20200319 | |
UniProtAcc | O76041 | Q03164 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000377159, ENST00000417816, ENST00000377119, ENST00000377122, ENST00000464278, | ENST00000420751, ENST00000354520, ENST00000389506, ENST00000534358, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 15 X 12 X 6=1080 | 31 X 72 X 3=6696 |
# samples | 16 | 79 | |
** MAII score | log2(16/1080*10)=-2.75488750216347 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(79/6696*10)=-3.08337496948588 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: NEBL [Title/Abstract] AND KMT2A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | KMT2A(118353224)-NEBL(21250710), # samples:1 NEBL(21309045)-KMT2A(118354896), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | NEBL-KMT2A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NEBL-KMT2A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. NEBL-KMT2A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. NEBL-KMT2A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | KMT2A | GO:0044648 | histone H3-K4 dimethylation | 25561738 |
Tgene | KMT2A | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20861184 |
Tgene | KMT2A | GO:0051568 | histone H3-K4 methylation | 19556245 |
Tgene | KMT2A | GO:0065003 | protein-containing complex assembly | 15199122 |
Tgene | KMT2A | GO:0080182 | histone H3-K4 trimethylation | 20861184 |
Tgene | KMT2A | GO:0097692 | histone H3-K4 monomethylation | 25561738|26324722 |
Fusion gene breakpoints across NEBL (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across KMT2A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | MH319862 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000417816 | NEBL | chr10 | 21309045 | - | ENST00000534358 | KMT2A | chr11 | 118354896 | + | 13088 | 603 | 354 | 8435 | 2693 |
ENST00000417816 | NEBL | chr10 | 21309045 | - | ENST00000389506 | KMT2A | chr11 | 118354896 | + | 10172 | 603 | 354 | 8426 | 2690 |
ENST00000417816 | NEBL | chr10 | 21309045 | - | ENST00000354520 | KMT2A | chr11 | 118354896 | + | 10837 | 603 | 354 | 8312 | 2652 |
ENST00000377159 | NEBL | chr10 | 21309045 | - | ENST00000534358 | KMT2A | chr11 | 118354896 | + | 12634 | 149 | 2 | 7981 | 2659 |
ENST00000377159 | NEBL | chr10 | 21309045 | - | ENST00000389506 | KMT2A | chr11 | 118354896 | + | 9718 | 149 | 2 | 7972 | 2656 |
ENST00000377159 | NEBL | chr10 | 21309045 | - | ENST00000354520 | KMT2A | chr11 | 118354896 | + | 10383 | 149 | 2 | 7858 | 2618 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000417816 | ENST00000534358 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + | 0.000368709 | 0.9996313 |
ENST00000417816 | ENST00000389506 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + | 0.000655885 | 0.99934405 |
ENST00000417816 | ENST00000354520 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + | 0.000760757 | 0.9992392 |
ENST00000377159 | ENST00000534358 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + | 0.000236956 | 0.9997631 |
ENST00000377159 | ENST00000389506 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + | 0.000422122 | 0.9995778 |
ENST00000377159 | ENST00000354520 | NEBL | chr10 | 21309045 | - | KMT2A | chr11 | 118354896 | + | 0.000485639 | 0.99951434 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >58344_58344_1_NEBL-KMT2A_NEBL_chr10_21309045_ENST00000377159_KMT2A_chr11_118354896_ENST00000354520_length(amino acids)=2618AA_BP=49 MLHFYYEWLHSGSRGAVPKPLHYPKQSFTTVADTPENLRLKQQSELQSQEKPPPVNKQENAGTLNILSTLSNGNSSKQKIPADGVHRIRV DFKFVYCQVCCEPFHKFCLEENERPLEDQLENWCCRRCKFCHVCGRQHQATKQLLECNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCV RCKSCGSTTPGKGWDAQWSHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYESKMMQCGKCDRWVHSKCENLSDEMYEILSNLPESVAYTC VNCTERHPAEWRLALEKELQISLKQVLTALLNSRTTSHLLRYRQAAKPPDLNPETEESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGV KRKMDQGNYTSVLEFSDDIVKIIQAAINSDGGQPEIKKANSMVKSFFIRQMERVFPWFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHN YAQWQEREENSHTEQPPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDRSREDSPELNPPPGIEDNRQCALCLTYGDDSANDAGRLL YIGQNEWTHVNCALWSAEVFEDDDGSLKNVHMAVIRGKQLRCEFCQKPGATVGCCLTSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLI KGEVVPENGFEVFRRVFVDFEGISLRRKFLNGLEPENIHMMIGSMTIDCLGILNDLSDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKI VECRPPVVEPDINSTVEHDENRTIAHSPTSFTESSSKESQNTAEIISPPSPDRPPHSQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRP LPSAGSPTPTTHEIVTVGDPLLSSGLRSIGSRRHSTSSLSPQRSKLRIMSPMRTGNTYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLN SSTSLGQNTSTSSNLQRTVVTVGNKNSHLDGSSSSEMKQSSASDLVSKSSSLKGEKTKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSR ELNVSKIGSFAEPSSVSFSSKEALSFPHLHLRGQRNDRDQHTDSTQSANSSPDEDTEVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKK SCKETFKEKHSSKSFLEPGQVTTGEEGNLKPEFMDEVLTPEYMGQRPCNNVSSDKIGDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVK VTLTPLKMENESQSKNALKESSPASPLQIESTSPTEPISASENPGDGPVAQPSPNNTSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGS FKRRYPRRSARARSNMFFGLTPLYGVRSYGEEDIPFYSSSTGKKRGKRSAEGQVDGADDLSTSDEDDLYYYNFTRTVISSGGEERLASHN LFREEEQCDLPKISQLDGVDDGTESDTSVTATTRKSSQIPKRNGKENGTENLKIDRPEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKT QGQDSLEAQLSSLESSRRVHTSTPSDKNLLDTYNTELLKSDSDNNNSDDCGNILPSDIMDFVLKNTPSMQALGESPESSSSELLNLGEGL GLDSNREKDMGLFEVFSQQLPTTEPVDSSVSSSISAEEQFELPLELPSDLSVLTTRSPTVPSQNPSRLAVISDSGEKRVTITEKSVASSE SDPALLSPGVDPTPEGHMTPDHFIQGHMDADHISSPPCGSVEQGHGNNQDLTRNSSTPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISN AAVQTTPPHLKPATEKLIVVNQNMQPLYVLQTLPNGVTQKIQLTSSVSSTPSVMETNTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASK GLLPMSHHQHLHSFPAATQSSFPPNISNPPSGLLIGVQPPPDPQLLVSESSQRTDLSTTVATPSSGLKKRPISRLQTRKNKKLAPSSTPS NIAPSDVVSNMTLINFTPSQLPNHPSLLDLGSLNTSSHRTVPNIIKRSKSSIMYFEPAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSV SGLASSSSVLNVVSMQTTTTPTSSASVPGHVTLTNPRLLGTPDIGSISNLLIKASQQSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAIT AASSICVLPSTQTTGITAASPSGEADEHYQLQHVNQLLASKTGIHSSQRDLDSASGPQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTS PGGSPSSPSSGQRSASPSVPGPTKPKPKTKRFQLPLDKGNGKKHKVSHLRTSSSEAHIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQ KECGQPAGQVAVLPEVQVTQNPANEQESAEPKTVEEEESNFSSPLMLWLQQEQKRKESITEKKPKKGLVFEISSDDGFQICAESIEDAWK SLTDKVQEARSNARLKQLSFAGVNGLRMLGILHDAVVFLIEQLSGAKHCRNYKFRFHKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFL ASKHRQPPEYNPNDEEEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKR EKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIVIFAMRKIYRGEELTYDYKFPIEDASNKLPCNCGA -------------------------------------------------------------- >58344_58344_2_NEBL-KMT2A_NEBL_chr10_21309045_ENST00000377159_KMT2A_chr11_118354896_ENST00000389506_length(amino acids)=2656AA_BP=49 MLHFYYEWLHSGSRGAVPKPLHYPKQSFTTVADTPENLRLKQQSELQSQEKPPPVNKQENAGTLNILSTLSNGNSSKQKIPADGVHRIRV DFKEDCEAENVWEMGGLGILTSVPITPRVVCFLCASSGHVEFVYCQVCCEPFHKFCLEENERPLEDQLENWCCRRCKFCHVCGRQHQATK QLLECNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCVRCKSCGSTTPGKGWDAQWSHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYES KMMQCGKCDRWVHSKCENLSDEMYEILSNLPESVAYTCVNCTERHPAEWRLALEKELQISLKQVLTALLNSRTTSHLLRYRQAAKPPDLN PETEESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGVKRKMDQGNYTSVLEFSDDIVKIIQAAINSDGGQPEIKKANSMVKSFFIRQME RVFPWFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHNYAQWQEREENSHTEQPPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDR SREDSPELNPPPGIEDNRQCALCLTYGDDSANDAGRLLYIGQNEWTHVNCALWSAEVFEDDDGSLKNVHMAVIRGKQLRCEFCQKPGATV GCCLTSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLIKGEVVPENGFEVFRRVFVDFEGISLRRKFLNGLEPENIHMMIGSMTIDCLGI LNDLSDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKIVECRPPVVEPDINSTVEHDENRTIAHSPTSFTESSSKESQNTAEIISPPSPD RPPHSQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRPLPSAGSPTPTTHEIVTVGDPLLSSGLRSIGSRRHSTSSLSPQRSKLRIMSPM RTGNTYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLNSSTSLGQNTSTSSNLQRTVVTVGNKNSHLDGSSSSEMKQSSASDLVSKSSSL KGEKTKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSRELNVSKIGSFAEPSSVSFSSKEALSFPHLHLRGQRNDRDQHTDSTQSANSSP DEDTEVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKKSCKETFKEKHSSKSFLEPGQVTTGEEGNLKPEFMDEVLTPEYMGQRPCNNVS SDKIGDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVKVTLTPLKMENESQSKNALKESSPASPLQIESTSPTEPISASENPGDGPVAQP SPNNTSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGSFKRRYPRRSARARSNMFFGLTPLYGVRSYGEEDIPFYSSSTGKKRGKRSAEG QVDGADDLSTSDEDDLYYYNFTRTVISSGGEERLASHNLFREEEQCDLPKISQLDGVDDGTESDTSVTATTRKSSQIPKRNGKENGTENL KIDRPEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKTQGQDSLEAQLSSLESSRRVHTSTPSDKNLLDTYNTELLKSDSDNNNSDDCGN ILPSDIMDFVLKNTPSMQALGESPESSSSELLNLGEGLGLDSNREKDMGLFEVFSQQLPTTEPVDSSVSSSISAEEQFELPLELPSDLSV LTTRSPTVPSQNPSRLAVISDSGEKRVTITEKSVASSESDPALLSPGVDPTPEGHMTPDHFIQGHMDADHISSPPCGSVEQGHGNNQDLT RNSSTPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISNAAVQTTPPHLKPATEKLIVVNQNMQPLYVLQTLPNGVTQKIQLTSSVSSTPS VMETNTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASKGLLPMSHHQHLHSFPAATQSSFPPNISNPPSGLLIGVQPPPDPQLLVSESSQ RTDLSTTVATPSSGLKKRPISRLQTRKNKKLAPSSTPSNIAPSDVVSNMTLINFTPSQLPNHPSLLDLGSLNTSSHRTVPNIIKRSKSSI MYFEPAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSVSGLASSSSVLNVVSMQTTTTPTSSASVPGHVTLTNPRLLGTPDIGSISNLLI KASQQSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAITAASSICVLPSTQTTGITAASPSGEADEHYQLQHVNQLLASKTGIHSSQRDLD SASGPQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTSPGGSPSSPSSGQRSASPSVPGPTKPKPKTKRFQLPLDKGNGKKHKVSHLRTS SSEAHIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQKECGQPAGQVAVLPEVQVTQNPANEQESAEPKTVEEEESNFSSPLMLWLQQE QKRKESITEKKPKKGLVFEISSDDGFQICAESIEDAWKSLTDKVQEARSNARLKQLSFAGVNGLRMLGILHDAVVFLIEQLSGAKHCRNY KFRFHKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFLASKHRQPPEYNPNDEEEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGV YRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQ -------------------------------------------------------------- >58344_58344_3_NEBL-KMT2A_NEBL_chr10_21309045_ENST00000377159_KMT2A_chr11_118354896_ENST00000534358_length(amino acids)=2659AA_BP=49 MLHFYYEWLHSGSRGAVPKPLHYPKQSFTTVADTPENLRLKQQSELQSQEKPPPVNKQENAGTLNILSTLSNGNSSKQKIPADGVHRIRV DFKEDCEAENVWEMGGLGILTSVPITPRVVCFLCASSGHVEFVYCQVCCEPFHKFCLEENERPLEDQLENWCCRRCKFCHVCGRQHQATK QLLECNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCVRCKSCGSTTPGKGWDAQWSHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYES KMMQCGKCDRWVHSKCENLSGTEDEMYEILSNLPESVAYTCVNCTERHPAEWRLALEKELQISLKQVLTALLNSRTTSHLLRYRQAAKPP DLNPETEESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGVKRKMDQGNYTSVLEFSDDIVKIIQAAINSDGGQPEIKKANSMVKSFFIR QMERVFPWFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHNYAQWQEREENSHTEQPPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILS TDRSREDSPELNPPPGIEDNRQCALCLTYGDDSANDAGRLLYIGQNEWTHVNCALWSAEVFEDDDGSLKNVHMAVIRGKQLRCEFCQKPG ATVGCCLTSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLIKGEVVPENGFEVFRRVFVDFEGISLRRKFLNGLEPENIHMMIGSMTIDC LGILNDLSDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKIVECRPPVVEPDINSTVEHDENRTIAHSPTSFTESSSKESQNTAEIISPP SPDRPPHSQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRPLPSAGSPTPTTHEIVTVGDPLLSSGLRSIGSRRHSTSSLSPQRSKLRIM SPMRTGNTYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLNSSTSLGQNTSTSSNLQRTVVTVGNKNSHLDGSSSSEMKQSSASDLVSKS SSLKGEKTKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSRELNVSKIGSFAEPSSVSFSSKEALSFPHLHLRGQRNDRDQHTDSTQSAN SSPDEDTEVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKKSCKETFKEKHSSKSFLEPGQVTTGEEGNLKPEFMDEVLTPEYMGQRPCN NVSSDKIGDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVKVTLTPLKMENESQSKNALKESSPASPLQIESTSPTEPISASENPGDGPV AQPSPNNTSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGSFKRRYPRRSARARSNMFFGLTPLYGVRSYGEEDIPFYSSSTGKKRGKRS AEGQVDGADDLSTSDEDDLYYYNFTRTVISSGGEERLASHNLFREEEQCDLPKISQLDGVDDGTESDTSVTATTRKSSQIPKRNGKENGT ENLKIDRPEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKTQGQDSLEAQLSSLESSRRVHTSTPSDKNLLDTYNTELLKSDSDNNNSDD CGNILPSDIMDFVLKNTPSMQALGESPESSSSELLNLGEGLGLDSNREKDMGLFEVFSQQLPTTEPVDSSVSSSISAEEQFELPLELPSD LSVLTTRSPTVPSQNPSRLAVISDSGEKRVTITEKSVASSESDPALLSPGVDPTPEGHMTPDHFIQGHMDADHISSPPCGSVEQGHGNNQ DLTRNSSTPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISNAAVQTTPPHLKPATEKLIVVNQNMQPLYVLQTLPNGVTQKIQLTSSVSS TPSVMETNTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASKGLLPMSHHQHLHSFPAATQSSFPPNISNPPSGLLIGVQPPPDPQLLVSE SSQRTDLSTTVATPSSGLKKRPISRLQTRKNKKLAPSSTPSNIAPSDVVSNMTLINFTPSQLPNHPSLLDLGSLNTSSHRTVPNIIKRSK SSIMYFEPAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSVSGLASSSSVLNVVSMQTTTTPTSSASVPGHVTLTNPRLLGTPDIGSISN LLIKASQQSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAITAASSICVLPSTQTTGITAASPSGEADEHYQLQHVNQLLASKTGIHSSQR DLDSASGPQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTSPGGSPSSPSSGQRSASPSVPGPTKPKPKTKRFQLPLDKGNGKKHKVSHL RTSSSEAHIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQKECGQPAGQVAVLPEVQVTQNPANEQESAEPKTVEEEESNFSSPLMLWL QQEQKRKESITEKKPKKGLVFEISSDDGFQICAESIEDAWKSLTDKVQEARSNARLKQLSFAGVNGLRMLGILHDAVVFLIEQLSGAKHC RNYKFRFHKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFLASKHRQPPEYNPNDEEEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEA VGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINI -------------------------------------------------------------- >58344_58344_4_NEBL-KMT2A_NEBL_chr10_21309045_ENST00000417816_KMT2A_chr11_118354896_ENST00000354520_length(amino acids)=2652AA_BP=83 MNPQCARCGKVVYPTEKVNCLDKYWHKGCFHCEVCKMALNMNNYKGYEKKPYCNAHYPKQSFTTVADTPENLRLKQQSELQSQEKPPPVN KQENAGTLNILSTLSNGNSSKQKIPADGVHRIRVDFKFVYCQVCCEPFHKFCLEENERPLEDQLENWCCRRCKFCHVCGRQHQATKQLLE CNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCVRCKSCGSTTPGKGWDAQWSHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYESKMMQ CGKCDRWVHSKCENLSDEMYEILSNLPESVAYTCVNCTERHPAEWRLALEKELQISLKQVLTALLNSRTTSHLLRYRQAAKPPDLNPETE ESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGVKRKMDQGNYTSVLEFSDDIVKIIQAAINSDGGQPEIKKANSMVKSFFIRQMERVFP WFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHNYAQWQEREENSHTEQPPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDRSRED SPELNPPPGIEDNRQCALCLTYGDDSANDAGRLLYIGQNEWTHVNCALWSAEVFEDDDGSLKNVHMAVIRGKQLRCEFCQKPGATVGCCL TSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLIKGEVVPENGFEVFRRVFVDFEGISLRRKFLNGLEPENIHMMIGSMTIDCLGILNDL SDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKIVECRPPVVEPDINSTVEHDENRTIAHSPTSFTESSSKESQNTAEIISPPSPDRPPH SQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRPLPSAGSPTPTTHEIVTVGDPLLSSGLRSIGSRRHSTSSLSPQRSKLRIMSPMRTGN TYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLNSSTSLGQNTSTSSNLQRTVVTVGNKNSHLDGSSSSEMKQSSASDLVSKSSSLKGEK TKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSRELNVSKIGSFAEPSSVSFSSKEALSFPHLHLRGQRNDRDQHTDSTQSANSSPDEDT EVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKKSCKETFKEKHSSKSFLEPGQVTTGEEGNLKPEFMDEVLTPEYMGQRPCNNVSSDKI GDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVKVTLTPLKMENESQSKNALKESSPASPLQIESTSPTEPISASENPGDGPVAQPSPNN TSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGSFKRRYPRRSARARSNMFFGLTPLYGVRSYGEEDIPFYSSSTGKKRGKRSAEGQVDG ADDLSTSDEDDLYYYNFTRTVISSGGEERLASHNLFREEEQCDLPKISQLDGVDDGTESDTSVTATTRKSSQIPKRNGKENGTENLKIDR PEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKTQGQDSLEAQLSSLESSRRVHTSTPSDKNLLDTYNTELLKSDSDNNNSDDCGNILPS DIMDFVLKNTPSMQALGESPESSSSELLNLGEGLGLDSNREKDMGLFEVFSQQLPTTEPVDSSVSSSISAEEQFELPLELPSDLSVLTTR SPTVPSQNPSRLAVISDSGEKRVTITEKSVASSESDPALLSPGVDPTPEGHMTPDHFIQGHMDADHISSPPCGSVEQGHGNNQDLTRNSS TPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISNAAVQTTPPHLKPATEKLIVVNQNMQPLYVLQTLPNGVTQKIQLTSSVSSTPSVMET NTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASKGLLPMSHHQHLHSFPAATQSSFPPNISNPPSGLLIGVQPPPDPQLLVSESSQRTDL STTVATPSSGLKKRPISRLQTRKNKKLAPSSTPSNIAPSDVVSNMTLINFTPSQLPNHPSLLDLGSLNTSSHRTVPNIIKRSKSSIMYFE PAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSVSGLASSSSVLNVVSMQTTTTPTSSASVPGHVTLTNPRLLGTPDIGSISNLLIKASQ QSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAITAASSICVLPSTQTTGITAASPSGEADEHYQLQHVNQLLASKTGIHSSQRDLDSASG PQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTSPGGSPSSPSSGQRSASPSVPGPTKPKPKTKRFQLPLDKGNGKKHKVSHLRTSSSEA HIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQKECGQPAGQVAVLPEVQVTQNPANEQESAEPKTVEEEESNFSSPLMLWLQQEQKRK ESITEKKPKKGLVFEISSDDGFQICAESIEDAWKSLTDKVQEARSNARLKQLSFAGVNGLRMLGILHDAVVFLIEQLSGAKHCRNYKFRF HKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFLASKHRQPPEYNPNDEEEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGVYRSP IHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFRIDDSEVVDATMHGNAARFINHSCEPNCYSRVINIDGQKHIV -------------------------------------------------------------- >58344_58344_5_NEBL-KMT2A_NEBL_chr10_21309045_ENST00000417816_KMT2A_chr11_118354896_ENST00000389506_length(amino acids)=2690AA_BP=83 MNPQCARCGKVVYPTEKVNCLDKYWHKGCFHCEVCKMALNMNNYKGYEKKPYCNAHYPKQSFTTVADTPENLRLKQQSELQSQEKPPPVN KQENAGTLNILSTLSNGNSSKQKIPADGVHRIRVDFKEDCEAENVWEMGGLGILTSVPITPRVVCFLCASSGHVEFVYCQVCCEPFHKFC LEENERPLEDQLENWCCRRCKFCHVCGRQHQATKQLLECNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCVRCKSCGSTTPGKGWDAQW SHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYESKMMQCGKCDRWVHSKCENLSDEMYEILSNLPESVAYTCVNCTERHPAEWRLALEKE LQISLKQVLTALLNSRTTSHLLRYRQAAKPPDLNPETEESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGVKRKMDQGNYTSVLEFSDD IVKIIQAAINSDGGQPEIKKANSMVKSFFIRQMERVFPWFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHNYAQWQEREENSHTEQPPL MKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDRSREDSPELNPPPGIEDNRQCALCLTYGDDSANDAGRLLYIGQNEWTHVNCALWSAE VFEDDDGSLKNVHMAVIRGKQLRCEFCQKPGATVGCCLTSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLIKGEVVPENGFEVFRRVFV DFEGISLRRKFLNGLEPENIHMMIGSMTIDCLGILNDLSDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKIVECRPPVVEPDINSTVEH DENRTIAHSPTSFTESSSKESQNTAEIISPPSPDRPPHSQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRPLPSAGSPTPTTHEIVTVG DPLLSSGLRSIGSRRHSTSSLSPQRSKLRIMSPMRTGNTYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLNSSTSLGQNTSTSSNLQRT VVTVGNKNSHLDGSSSSEMKQSSASDLVSKSSSLKGEKTKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSRELNVSKIGSFAEPSSVSF SSKEALSFPHLHLRGQRNDRDQHTDSTQSANSSPDEDTEVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKKSCKETFKEKHSSKSFLEP GQVTTGEEGNLKPEFMDEVLTPEYMGQRPCNNVSSDKIGDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVKVTLTPLKMENESQSKNAL KESSPASPLQIESTSPTEPISASENPGDGPVAQPSPNNTSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGSFKRRYPRRSARARSNMFF GLTPLYGVRSYGEEDIPFYSSSTGKKRGKRSAEGQVDGADDLSTSDEDDLYYYNFTRTVISSGGEERLASHNLFREEEQCDLPKISQLDG VDDGTESDTSVTATTRKSSQIPKRNGKENGTENLKIDRPEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKTQGQDSLEAQLSSLESSRR VHTSTPSDKNLLDTYNTELLKSDSDNNNSDDCGNILPSDIMDFVLKNTPSMQALGESPESSSSELLNLGEGLGLDSNREKDMGLFEVFSQ QLPTTEPVDSSVSSSISAEEQFELPLELPSDLSVLTTRSPTVPSQNPSRLAVISDSGEKRVTITEKSVASSESDPALLSPGVDPTPEGHM TPDHFIQGHMDADHISSPPCGSVEQGHGNNQDLTRNSSTPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISNAAVQTTPPHLKPATEKLI VVNQNMQPLYVLQTLPNGVTQKIQLTSSVSSTPSVMETNTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASKGLLPMSHHQHLHSFPAAT QSSFPPNISNPPSGLLIGVQPPPDPQLLVSESSQRTDLSTTVATPSSGLKKRPISRLQTRKNKKLAPSSTPSNIAPSDVVSNMTLINFTP SQLPNHPSLLDLGSLNTSSHRTVPNIIKRSKSSIMYFEPAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSVSGLASSSSVLNVVSMQTT TTPTSSASVPGHVTLTNPRLLGTPDIGSISNLLIKASQQSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAITAASSICVLPSTQTTGITA ASPSGEADEHYQLQHVNQLLASKTGIHSSQRDLDSASGPQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTSPGGSPSSPSSGQRSASPS VPGPTKPKPKTKRFQLPLDKGNGKKHKVSHLRTSSSEAHIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQKECGQPAGQVAVLPEVQV TQNPANEQESAEPKTVEEEESNFSSPLMLWLQQEQKRKESITEKKPKKGLVFEISSDDGFQICAESIEDAWKSLTDKVQEARSNARLKQL SFAGVNGLRMLGILHDAVVFLIEQLSGAKHCRNYKFRFHKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFLASKHRQPPEYNPNDEEEE EVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFRIDD -------------------------------------------------------------- >58344_58344_6_NEBL-KMT2A_NEBL_chr10_21309045_ENST00000417816_KMT2A_chr11_118354896_ENST00000534358_length(amino acids)=2693AA_BP=83 MNPQCARCGKVVYPTEKVNCLDKYWHKGCFHCEVCKMALNMNNYKGYEKKPYCNAHYPKQSFTTVADTPENLRLKQQSELQSQEKPPPVN KQENAGTLNILSTLSNGNSSKQKIPADGVHRIRVDFKEDCEAENVWEMGGLGILTSVPITPRVVCFLCASSGHVEFVYCQVCCEPFHKFC LEENERPLEDQLENWCCRRCKFCHVCGRQHQATKQLLECNKCRNSYHPECLGPNYPTKPTKKKKVWICTKCVRCKSCGSTTPGKGWDAQW SHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYESKMMQCGKCDRWVHSKCENLSGTEDEMYEILSNLPESVAYTCVNCTERHPAEWRLAL EKELQISLKQVLTALLNSRTTSHLLRYRQAAKPPDLNPETEESIPSRSSPEGPDPPVLTEVSKQDDQQPLDLEGVKRKMDQGNYTSVLEF SDDIVKIIQAAINSDGGQPEIKKANSMVKSFFIRQMERVFPWFSVKKSRFWEPNKVSSNSGMLPNAVLPPSLDHNYAQWQEREENSHTEQ PPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDRSREDSPELNPPPGIEDNRQCALCLTYGDDSANDAGRLLYIGQNEWTHVNCALW SAEVFEDDDGSLKNVHMAVIRGKQLRCEFCQKPGATVGCCLTSCTSNYHFMCSRAKNCVFLDDKKVYCQRHRDLIKGEVVPENGFEVFRR VFVDFEGISLRRKFLNGLEPENIHMMIGSMTIDCLGILNDLSDCEDKLFPIGYQCSRVYWSTTDARKRCVYTCKIVECRPPVVEPDINST VEHDENRTIAHSPTSFTESSSKESQNTAEIISPPSPDRPPHSQTSGSCYYHVISKVPRIRTPSYSPTQRSPGCRPLPSAGSPTPTTHEIV TVGDPLLSSGLRSIGSRRHSTSSLSPQRSKLRIMSPMRTGNTYSRNNVSSVSTTGTATDLESSAKVVDHVLGPLNSSTSLGQNTSTSSNL QRTVVTVGNKNSHLDGSSSSEMKQSSASDLVSKSSSLKGEKTKVLSSKSSEGSAHNVAYPGIPKLAPQVHNTTSRELNVSKIGSFAEPSS VSFSSKEALSFPHLHLRGQRNDRDQHTDSTQSANSSPDEDTEVKTLKLSGMSNRSSIINEHMGSSSRDRRQKGKKSCKETFKEKHSSKSF LEPGQVTTGEEGNLKPEFMDEVLTPEYMGQRPCNNVSSDKIGDKGLSMPGVPKAPPMQVEGSAKELQAPRKRTVKVTLTPLKMENESQSK NALKESSPASPLQIESTSPTEPISASENPGDGPVAQPSPNNTSCQDSQSNNYQNLPVQDRNLMLPDGPKPQEDGSFKRRYPRRSARARSN MFFGLTPLYGVRSYGEEDIPFYSSSTGKKRGKRSAEGQVDGADDLSTSDEDDLYYYNFTRTVISSGGEERLASHNLFREEEQCDLPKISQ LDGVDDGTESDTSVTATTRKSSQIPKRNGKENGTENLKIDRPEDAGEKEHVTKSSVGHKNEPKMDNCHSVSRVKTQGQDSLEAQLSSLES SRRVHTSTPSDKNLLDTYNTELLKSDSDNNNSDDCGNILPSDIMDFVLKNTPSMQALGESPESSSSELLNLGEGLGLDSNREKDMGLFEV FSQQLPTTEPVDSSVSSSISAEEQFELPLELPSDLSVLTTRSPTVPSQNPSRLAVISDSGEKRVTITEKSVASSESDPALLSPGVDPTPE GHMTPDHFIQGHMDADHISSPPCGSVEQGHGNNQDLTRNSSTPGLQVPVSPTVPIQNQKYVPNSTDSPGPSQISNAAVQTTPPHLKPATE KLIVVNQNMQPLYVLQTLPNGVTQKIQLTSSVSSTPSVMETNTSVLGPMGGGLTLTTGLNPSLPTSQSLFPSASKGLLPMSHHQHLHSFP AATQSSFPPNISNPPSGLLIGVQPPPDPQLLVSESSQRTDLSTTVATPSSGLKKRPISRLQTRKNKKLAPSSTPSNIAPSDVVSNMTLIN FTPSQLPNHPSLLDLGSLNTSSHRTVPNIIKRSKSSIMYFEPAPLLPQSVGGTAATAAGTSTISQDTSHLTSGSVSGLASSSSVLNVVSM QTTTTPTSSASVPGHVTLTNPRLLGTPDIGSISNLLIKASQQSLGIQDQPVALPPSSGMFPQLGTSQTPSTAAITAASSICVLPSTQTTG ITAASPSGEADEHYQLQHVNQLLASKTGIHSSQRDLDSASGPQVSNFTQTVDAPNSMGLEQNKALSSAVQASPTSPGGSPSSPSSGQRSA SPSVPGPTKPKPKTKRFQLPLDKGNGKKHKVSHLRTSSSEAHIPDQETTSLTSGTGTPGAEAEQQDTASVEQSSQKECGQPAGQVAVLPE VQVTQNPANEQESAEPKTVEEEESNFSSPLMLWLQQEQKRKESITEKKPKKGLVFEISSDDGFQICAESIEDAWKSLTDKVQEARSNARL KQLSFAGVNGLRMLGILHDAVVFLIEQLSGAKHCRNYKFRFHKPEEANEPPLNPHGSARAEVHLRKSAFDMFNFLASKHRQPPEYNPNDE EEEEVQLKSARRATSMDLPMPMRFRHLKKTSKEAVGVYRSPIHGRGLFCKRNIDAGEMVIEYAGNVIRSIQTDKREKYYDSKGIGCYMFR -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:118353224/chr11:21250710) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NEBL | KMT2A |
FUNCTION: Binds to actin and plays an important role in the assembly of the Z-disk. May functionally link sarcomeric actin to the desmin intermediate filaments in the heart muscle sarcomeres (PubMed:27733623). Isoform 2 might play a role in the assembly of focal adhesion (PubMed:15004028). {ECO:0000269|PubMed:15004028, ECO:0000269|PubMed:27733623}. | FUNCTION: Histone methyltransferase that plays an essential role in early development and hematopoiesis (PubMed:15960975, PubMed:12453419, PubMed:15960975, PubMed:19556245, PubMed:19187761, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac) (PubMed:15960975, PubMed:12453419, PubMed:15960975, PubMed:19556245, PubMed:24235145, PubMed:19187761, PubMed:20677832, PubMed:21220120, PubMed:26886794). Catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism. Part of chromatin remodeling machinery predominantly forms H3K4me1 and H3K4me2 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:25561738, PubMed:15960975, PubMed:12453419, PubMed:15960975, PubMed:19556245, PubMed:19187761, PubMed:20677832, PubMed:21220120, PubMed:26886794). Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity (PubMed:19187761, PubMed:26886794). Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9' (PubMed:19187761). Binds to unmethylated CpG elements in the promoter of target genes and helps maintain them in the nonmethylated state (PubMed:20010842). Required for transcriptional activation of HOXA9 (PubMed:12453419, PubMed:20677832, PubMed:20010842). Promotes PPP1R15A-induced apoptosis (PubMed:10490642). Plays a critical role in the control of circadian gene expression and is essential for the transcriptional activation mediated by the CLOCK-ARNTL/BMAL1 heterodimer (By similarity). Establishes a permissive chromatin state for circadian transcription by mediating a rhythmic methylation of 'Lys-4' of histone H3 (H3K4me) and this histone modification directs the circadian acetylation at H3K9 and H3K14 allowing the recruitment of CLOCK-ARNTL/BMAL1 to chromatin (By similarity). Also has auto-methylation activity on Cys-3882 in absence of histone H3 substrate (PubMed:24235145). {ECO:0000250|UniProtKB:P55200, ECO:0000269|PubMed:10490642, ECO:0000269|PubMed:12453419, ECO:0000269|PubMed:15960975, ECO:0000269|PubMed:19187761, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:20010842, ECO:0000269|PubMed:21220120, ECO:0000269|PubMed:24235145, ECO:0000269|PubMed:26886794, ECO:0000305|PubMed:20677832}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 29_63 | 83.0 | 271.0 | Repeat | Note=Nebulin 1 |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1703_1748 | 1362.0 | 3932.0 | Domain | Bromo%3B divergent | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 2018_2074 | 1362.0 | 3932.0 | Domain | FYR N-terminal | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 3666_3747 | 1362.0 | 3932.0 | Domain | FYR C-terminal | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 3829_3945 | 1362.0 | 3932.0 | Domain | SET | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 3953_3969 | 1362.0 | 3932.0 | Domain | Post-SET | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1703_1748 | 1362.0 | 3970.0 | Domain | Bromo%3B divergent | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 2018_2074 | 1362.0 | 3970.0 | Domain | FYR N-terminal | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 3666_3747 | 1362.0 | 3970.0 | Domain | FYR C-terminal | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 3829_3945 | 1362.0 | 3970.0 | Domain | SET | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 3953_3969 | 1362.0 | 3970.0 | Domain | Post-SET | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1703_1748 | 1362.0 | 3973.0 | Domain | Bromo%3B divergent | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 2018_2074 | 1362.0 | 3973.0 | Domain | FYR N-terminal | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 3666_3747 | 1362.0 | 3973.0 | Domain | FYR C-terminal | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 3829_3945 | 1362.0 | 3973.0 | Domain | SET | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 3953_3969 | 1362.0 | 3973.0 | Domain | Post-SET | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 3906_3907 | 1362.0 | 3932.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 3906_3907 | 1362.0 | 3970.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 3906_3907 | 1362.0 | 3973.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1431_1482 | 1362.0 | 3932.0 | Zinc finger | PHD-type 1 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1479_1533 | 1362.0 | 3932.0 | Zinc finger | PHD-type 2 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1566_1627 | 1362.0 | 3932.0 | Zinc finger | PHD-type 3 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1870_1910 | 1362.0 | 3932.0 | Zinc finger | C2HC pre-PHD-type | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1931_1978 | 1362.0 | 3932.0 | Zinc finger | PHD-type 4 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1431_1482 | 1362.0 | 3970.0 | Zinc finger | PHD-type 1 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1479_1533 | 1362.0 | 3970.0 | Zinc finger | PHD-type 2 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1566_1627 | 1362.0 | 3970.0 | Zinc finger | PHD-type 3 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1870_1910 | 1362.0 | 3970.0 | Zinc finger | C2HC pre-PHD-type | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1931_1978 | 1362.0 | 3970.0 | Zinc finger | PHD-type 4 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1431_1482 | 1362.0 | 3973.0 | Zinc finger | PHD-type 1 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1479_1533 | 1362.0 | 3973.0 | Zinc finger | PHD-type 2 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1566_1627 | 1362.0 | 3973.0 | Zinc finger | PHD-type 3 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1870_1910 | 1362.0 | 3973.0 | Zinc finger | C2HC pre-PHD-type | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1931_1978 | 1362.0 | 3973.0 | Zinc finger | PHD-type 4 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 954_1014 | 0 | 1015.0 | Domain | SH3 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 954_1014 | 83.0 | 271.0 | Domain | SH3 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 836_953 | 0 | 1015.0 | Region | Note=Linker |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 836_953 | 83.0 | 271.0 | Region | Note=Linker |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 100_136 | 0 | 1015.0 | Repeat | Note=Nebulin 3 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 137_172 | 0 | 1015.0 | Repeat | Note=Nebulin 4 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 173_205 | 0 | 1015.0 | Repeat | Note=Nebulin 5 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 206_241 | 0 | 1015.0 | Repeat | Note=Nebulin 6 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 242_278 | 0 | 1015.0 | Repeat | Note=Nebulin 7 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 279_313 | 0 | 1015.0 | Repeat | Note=Nebulin 8 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 29_63 | 0 | 1015.0 | Repeat | Note=Nebulin 1 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 314_348 | 0 | 1015.0 | Repeat | Note=Nebulin 9 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 349_385 | 0 | 1015.0 | Repeat | Note=Nebulin 10 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 386_422 | 0 | 1015.0 | Repeat | Note=Nebulin 11 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 423_459 | 0 | 1015.0 | Repeat | Note=Nebulin 12 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 460_496 | 0 | 1015.0 | Repeat | Note=Nebulin 13 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 497_533 | 0 | 1015.0 | Repeat | Note=Nebulin 14 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 534_569 | 0 | 1015.0 | Repeat | Note=Nebulin 15 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 570_599 | 0 | 1015.0 | Repeat | Note=Nebulin 16 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 600_635 | 0 | 1015.0 | Repeat | Note=Nebulin 17 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 636_666 | 0 | 1015.0 | Repeat | Note=Nebulin 18 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 64_99 | 0 | 1015.0 | Repeat | Note=Nebulin 2 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 667_693 | 0 | 1015.0 | Repeat | Note=Nebulin 19 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 694_728 | 0 | 1015.0 | Repeat | Note=Nebulin 20 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 729_759 | 0 | 1015.0 | Repeat | Note=Nebulin 21 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 760_794 | 0 | 1015.0 | Repeat | Note=Nebulin 22 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000377122 | - | 1 | 28 | 795_830 | 0 | 1015.0 | Repeat | Note=Nebulin 23 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 100_136 | 83.0 | 271.0 | Repeat | Note=Nebulin 3 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 137_172 | 83.0 | 271.0 | Repeat | Note=Nebulin 4 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 173_205 | 83.0 | 271.0 | Repeat | Note=Nebulin 5 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 206_241 | 83.0 | 271.0 | Repeat | Note=Nebulin 6 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 242_278 | 83.0 | 271.0 | Repeat | Note=Nebulin 7 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 279_313 | 83.0 | 271.0 | Repeat | Note=Nebulin 8 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 314_348 | 83.0 | 271.0 | Repeat | Note=Nebulin 9 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 349_385 | 83.0 | 271.0 | Repeat | Note=Nebulin 10 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 386_422 | 83.0 | 271.0 | Repeat | Note=Nebulin 11 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 423_459 | 83.0 | 271.0 | Repeat | Note=Nebulin 12 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 460_496 | 83.0 | 271.0 | Repeat | Note=Nebulin 13 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 497_533 | 83.0 | 271.0 | Repeat | Note=Nebulin 14 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 534_569 | 83.0 | 271.0 | Repeat | Note=Nebulin 15 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 570_599 | 83.0 | 271.0 | Repeat | Note=Nebulin 16 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 600_635 | 83.0 | 271.0 | Repeat | Note=Nebulin 17 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 636_666 | 83.0 | 271.0 | Repeat | Note=Nebulin 18 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 64_99 | 83.0 | 271.0 | Repeat | Note=Nebulin 2 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 667_693 | 83.0 | 271.0 | Repeat | Note=Nebulin 19 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 694_728 | 83.0 | 271.0 | Repeat | Note=Nebulin 20 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 729_759 | 83.0 | 271.0 | Repeat | Note=Nebulin 21 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 760_794 | 83.0 | 271.0 | Repeat | Note=Nebulin 22 |
Hgene | NEBL | chr10:21309045 | chr11:118354896 | ENST00000417816 | - | 3 | 7 | 795_830 | 83.0 | 271.0 | Repeat | Note=Nebulin 23 |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 137_143 | 1362.0 | 3932.0 | Compositional bias | Note=Poly-Gly | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 17_102 | 1362.0 | 3932.0 | Compositional bias | Note=Ala/Gly/Ser-rich | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 561_564 | 1362.0 | 3932.0 | Compositional bias | Note=Poly-Pro | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 568_571 | 1362.0 | 3932.0 | Compositional bias | Note=Poly-Pro | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 137_143 | 1362.0 | 3970.0 | Compositional bias | Note=Poly-Gly | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 17_102 | 1362.0 | 3970.0 | Compositional bias | Note=Ala/Gly/Ser-rich | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 561_564 | 1362.0 | 3970.0 | Compositional bias | Note=Poly-Pro | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 568_571 | 1362.0 | 3970.0 | Compositional bias | Note=Poly-Pro | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 137_143 | 1362.0 | 3973.0 | Compositional bias | Note=Poly-Gly | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 17_102 | 1362.0 | 3973.0 | Compositional bias | Note=Ala/Gly/Ser-rich | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 561_564 | 1362.0 | 3973.0 | Compositional bias | Note=Poly-Pro | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 568_571 | 1362.0 | 3973.0 | Compositional bias | Note=Poly-Pro | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 169_180 | 1362.0 | 3932.0 | DNA binding | Note=A.T hook 1 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 217_227 | 1362.0 | 3932.0 | DNA binding | Note=A.T hook 2 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 301_309 | 1362.0 | 3932.0 | DNA binding | Note=A.T hook 3 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 169_180 | 1362.0 | 3970.0 | DNA binding | Note=A.T hook 1 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 217_227 | 1362.0 | 3970.0 | DNA binding | Note=A.T hook 2 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 301_309 | 1362.0 | 3970.0 | DNA binding | Note=A.T hook 3 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 169_180 | 1362.0 | 3973.0 | DNA binding | Note=A.T hook 1 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 217_227 | 1362.0 | 3973.0 | DNA binding | Note=A.T hook 2 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 301_309 | 1362.0 | 3973.0 | DNA binding | Note=A.T hook 3 | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 123_134 | 1362.0 | 3932.0 | Motif | Integrase domain-binding motif 1 (IBM1) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 147_152 | 1362.0 | 3932.0 | Motif | Integrase domain-binding motif 2 (IBM2) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 6_25 | 1362.0 | 3932.0 | Motif | Menin-binding motif (MBM) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 123_134 | 1362.0 | 3970.0 | Motif | Integrase domain-binding motif 1 (IBM1) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 147_152 | 1362.0 | 3970.0 | Motif | Integrase domain-binding motif 2 (IBM2) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 6_25 | 1362.0 | 3970.0 | Motif | Menin-binding motif (MBM) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 123_134 | 1362.0 | 3973.0 | Motif | Integrase domain-binding motif 1 (IBM1) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 147_152 | 1362.0 | 3973.0 | Motif | Integrase domain-binding motif 2 (IBM2) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 6_25 | 1362.0 | 3973.0 | Motif | Menin-binding motif (MBM) | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000354520 | 7 | 35 | 1147_1195 | 1362.0 | 3932.0 | Zinc finger | CXXC-type | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000389506 | 7 | 36 | 1147_1195 | 1362.0 | 3970.0 | Zinc finger | CXXC-type | |
Tgene | KMT2A | chr10:21309045 | chr11:118354896 | ENST00000534358 | 7 | 36 | 1147_1195 | 1362.0 | 3973.0 | Zinc finger | CXXC-type |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
KMT2A | PPIE, PPP1R15A, KMT2A, ASH2L, HCFC1, HCFC2, MEN1, RBBP5, WDR5, AVP, INS, OXT, MAP3K5, HDAC1, CTBP1, CBX4, BMI1, CREBBP, SMARCB1, CXXC1, MYB, CTNNB1, SNW1, E2F2, E2F4, E2F6, PSIP1, MLLT4, POLR2A, KAT8, RNF2, TP53, tat, SBF1, MTM1, SET, HIST1H3A, HIST1H4A, KAT6A, ELL, AFF1, AFF4, CDK9, CCNT1, CTR9, LEO1, PAF1, CDC73, WDR61, MLLT3, DOT1L, SKP2, HIST3H3, SVIL, HIST2H3C, SIN3A, MLLT1, RUNX1, CBFB, H3F3A, SIRT7, ASB2, TCEB1, TCEB2, CBX8, TOP1, TAF6, NCL, HECW2, LGR4, CSNK2A2, SENP3, SYMPK, PKN1, PIH1D1, KRAS, TAF1, CHD3, SMARCA2, SMARCC2, SMARCC1, HDAC2, RBBP4, RBBP7, TBP, MBD3, SAP30, RAN, TAF9, TASP1, HIST1H2BG, EWSR1, DYNLT1, KIF11, ING4, Cbx1, Set, ZNF131, ASB7, AR, CSNK2A1, OGT, BRD4, KDM5B, KDM5D, KDM6B, CKS1B, CKS2, CHD4, ESR2, AGR2, EZH2, FBXW7, SOX2, MED17, WDR82, ACTR8, GEMIN5, RUVBL1, MCM2, RTF1, MED15, MED8, MRGBP, MED14, HIST1H2BB, HIST1H2AB, KIAA1429, SP1, MYC, NR2C2, IRF2, PLEKHA4, DPY30, PTEN, NPM1, RPL13, CCT6A, TMCO1, ITGB1, ESR1, MYCN, SUPT5H, CIT, Pik3r2, FASN, LDLR, CDC27, KMT2B, SETD1A, KDM6A, KANSL2, BUB3, SETD1B, KANSL1, RERE, MCRS1, KMT2C, ZZZ3, MBIP, YEATS2, PAXIP1, KANSL3, KMT2D, BOD1L1, CSRP2BP, ZNF608, ATN1, PHF20L1, PHF20, NCOA6, TADA3, APEX1, ASF1A, CBX3, CD3EAP, CENPA, NUP50, POLR1E, TERF2IP, ZNF330, NAA40, PRKRA, SRSF4, KRR1, RPL13A, ABT1, CSNK2B, OASL, SRSF5, SRSF6, RPS9, FGFBP1, RPLP0, RPL36, KAL1, RPL3, PML, ELF1, ELF2, FEV, NHLH1, EN1, KLF12, KLF3, NFIX, NFYC, YY1, BRD3, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
NEBL | |
KMT2A |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to NEBL-KMT2A |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to NEBL-KMT2A |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | KMT2A | C2826025 | Mixed phenotype acute leukemia | 3 | ORPHANET |
Tgene | KMT2A | C0023418 | leukemia | 2 | CTD_human |
Tgene | KMT2A | C0023452 | Childhood Acute Lymphoblastic Leukemia | 2 | CTD_human |
Tgene | KMT2A | C0023453 | L2 Acute Lymphoblastic Leukemia | 2 | CTD_human |
Tgene | KMT2A | C0023466 | Leukemia, Monocytic, Chronic | 2 | CTD_human |
Tgene | KMT2A | C0023467 | Leukemia, Myelocytic, Acute | 2 | CTD_human |
Tgene | KMT2A | C0023470 | Myeloid Leukemia | 2 | CTD_human |
Tgene | KMT2A | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Tgene | KMT2A | C1854630 | Growth Deficiency and Mental Retardation with Facial Dysmorphism | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | KMT2A | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Tgene | KMT2A | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2 | CTD_human |
Tgene | KMT2A | C0001418 | Adenocarcinoma | 1 | CTD_human |
Tgene | KMT2A | C0004403 | Autosome Abnormalities | 1 | CTD_human |
Tgene | KMT2A | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Tgene | KMT2A | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Tgene | KMT2A | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Tgene | KMT2A | C0008625 | Chromosome Aberrations | 1 | CTD_human |
Tgene | KMT2A | C0023448 | Lymphoid leukemia | 1 | CTD_human |
Tgene | KMT2A | C0023465 | Acute monocytic leukemia | 1 | CTD_human |
Tgene | KMT2A | C0023479 | Acute myelomonocytic leukemia | 1 | CTD_human |
Tgene | KMT2A | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Tgene | KMT2A | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | KMT2A | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | KMT2A | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | KMT2A | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
Tgene | KMT2A | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Tgene | KMT2A | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Tgene | KMT2A | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Tgene | KMT2A | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Tgene | KMT2A | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Tgene | KMT2A | C0270972 | Cornelia De Lange Syndrome | 1 | ORPHANET |
Tgene | KMT2A | C0280141 | Acute Undifferentiated Leukemia | 1 | ORPHANET |
Tgene | KMT2A | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Tgene | KMT2A | C0856823 | Undifferentiated type acute leukemia | 1 | ORPHANET |
Tgene | KMT2A | C1535926 | Neurodevelopmental Disorders | 1 | CTD_human |
Tgene | KMT2A | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Tgene | KMT2A | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | KMT2A | C2930974 | Acute erythroleukemia | 1 | CTD_human |
Tgene | KMT2A | C2930975 | Acute erythroleukemia - M6a subtype | 1 | CTD_human |
Tgene | KMT2A | C2930976 | Acute myeloid leukemia FAB-M6 | 1 | CTD_human |
Tgene | KMT2A | C2930977 | Acute erythroleukemia - M6b subtype | 1 | CTD_human |